We’re helping to build a legacy that sparks hope through clinical trials. Learn how you can make a difference in the future of medicine. | Regeneron
0:09
We’re helping to build a legacy that sparks hope through clinical trials. Learn how you can make a difference in the future of medicine. | Regeneron
4.9K views1 year ago
FacebookRegeneron
We’re using CRISPR “knock-in” and “knock-out” technology inside the body to potentially tackle difficult-to-treat genetic conditions. | Regeneron
0:15
We’re using CRISPR “knock-in” and “knock-out” technology inside the body to potentially tackle difficult-to-treat genetic conditions. | Regeneron
420.7K viewsOct 26, 2023
FacebookRegeneron
Through clinical trials, we can answer more questions, develop more potentially life-changing medicines, and discover more possibilities. | Regeneron
0:31
Through clinical trials, we can answer more questions, develop more potentially life-changing medicines, and discover more possibilities. | Regeneron
124.7K viewsNov 20, 2024
FacebookRegeneron
Roche, Regeneron link up on antibodies
1:03
Roche, Regeneron link up on antibodies
11.1K viewsAug 19, 2020
YahooReuters Videos
Regeneron Antibody Research & Medicines
Regeneron Antibody Research & Medicines
Dec 4, 2024
regeneron.com
Our approach to precision medicine follows three critical steps: 1. Use biomarkers during clinical trials 2. Conduct as much translational research as possible 3. Identify biomarkers that support personalized or predictive medicine. Learn more about the process from #RegeneronScientist, Jennifer Hamilton. | Regeneron
1:24
Our approach to precision medicine follows three critical steps: 1. Use biomarkers during clinical trials 2. Conduct as much translational research as possible 3. Identify biomarkers that support personalized or predictive medicine. Learn more about the process from #RegeneronScientist, Jennifer Hamilton. | Regeneron
568 viewsOct 23, 2019
FacebookRegeneron
Since our earliest days, we’ve believed that transforming human health takes bold scientific ambition and a deep sense of responsibility. At Regeneron, we pursue breakthrough science and technology with a long-term view, and measure success not just by progress in the lab, but by the impact we have on each patient, colleague and shareholder. Science drives our work, and responsibility fuels it. By staying focused on what matters most to our stakeholders, we’re building a resilient, responsible b
0:36
Since our earliest days, we’ve believed that transforming human health takes bold scientific ambition and a deep sense of responsibility. At Regeneron, we pursue breakthrough science and technology with a long-term view, and measure success not just by progress in the lab, but by the impact we have on each patient, colleague and shareholder. Science drives our work, and responsibility fuels it. By staying focused on what matters most to our stakeholders, we’re building a resilient, responsible b
774 viewsApr 30, 2025
FacebookRegeneron
0:28
One thing we’ve learned is that innovation isn’t easy — because real breakthroughs come from challenging everything we think we know. 🤯 At Regeneron, they’ve come from rethinking assumptions, identifying and removing bottlenecks and finding the simplest fundamental truths buried under all the world’s complexity. 🌎 Today’s global health challenges depend on bold, radical innovation. Our CSO George Yancopoulos shares five key principles that guide our scientific curiosity from groundbreaking ide
732 viewsApr 4, 2025
FacebookRegeneron
3:05
Regeneron aims for COVID-19 drug trials by early summer
Mar 17, 2020
CNBCMeg Tirrell
4:21
Why Regeneron's antibody drug will be in short supply
Nov 2, 2020
CNBCMeg Tirrell
0:08
Clinical trials today shape tomorrow’s medicines. Learn how your involvement can help make an impact. | Regeneron
26.7K views1 year ago
FacebookRegeneron
0:54
Regeneron receives $450 million federal contract for Covid-19 antibody drug
Jul 7, 2020
CNBCMeg Tirrell
0:06
Regeneron was founded in pursuit of more. See how we move science to medicine because our world is meant for more. | Regeneron
592.1K viewsOct 15, 2024
FacebookRegeneron
6:25
Regeneron Pharmaceuticals: A Strong Contender in the Biotech Arena | The Motley Fool
1 month ago
fool.com
8:05
Regeneron CEO on first-ever FDA approved gene therapy to restore hearing
3 weeks ago
CNBCAnnika Kim Constantino
Regeneron Pharmaceuticals (NasdaqGS:REGN) Reports 27% Reduction In COPD Exacerbations In Phase 3 Trial
11 months ago
Yahooeditorial-team@simplywallst.com (Simply Wall St)
2:18
Regeneron Covid-19 'antibody cocktail' drug enters late-stage trials
Jul 6, 2020
CNBCMeg Tirrell
2:49
Regeneron Pharmaceuticals will develop and release a “next generation” antibody treatment against the omicron variant early next year after the company said its current antibody cocktail loses potency against the new Covid variant, as the U.S. races to curb a surge of cases across the country. Read More: https://www.forbes.com/sites/annakaplan/2021/12/16/regeneron-developing-new-antibody-covid-cocktail-current-treatment-less-effective-against-omicron/?sh=33969eb0221f&utm_source=FBPAGE&utm_medium
2.4K viewsDec 16, 2021
FacebookForbes
What is Regeneron: 5 things to know about the Westchester-based pharmaceutical company
Oct 7, 2020
lohud.com
Trump announces deal with Regeneron Pharmaceuticals, reducing drug prices
2 weeks ago
oann.com
0:38
Regeneron enters Phase 3 of trials for COVID-19 treatment
7 months ago
cbs6albany.com
0:43
🌟 Yesterday we announced our plans to acquire 23andMe and maintain its operations as a top consumer genetics company. We’re excited to strengthen our leadership in genetics-guided research and drug development for the betterment of patients, while prioritizing the privacy, security and ethical use of 23andMe’s customer data. We are committed to handling the data and services with the utmost care and aim to unlock 23andMe's full potential to benefit individual health and society as a whole. 💡💪
1.7K views1 year ago
FacebookRegeneron
2:13
FDA approves Regeneron’s Covid-19 antibody treatment
Nov 22, 2020
NBC News
3:15
Regeneron president on new data revealing COVID-19 antibody cocktail significantly reduces infection risk
Nov 10, 2021
Fox BusinessTalia Kaplan
7:24
Regeneron CEO on coronavirus drug timeline
Mar 3, 2020
CNBC
0:30
From discovery to manufacturing, we're aiming to do more for patients. | Regeneron
93.7K viewsApr 25, 2025
FacebookRegeneron
4:08
Inside The Gene Factory | Forbes
5.4K viewsMay 29, 2018
YouTubeForbes
1:41
What drives a clinical trial investigator? The chance to support progress in science for patients. | Regeneron
23.8K views7 months ago
FacebookRegeneron
0:16
Today marks the start of our annual Day for Doing Good, our company-wide global days of service. With over 4,000 volunteers and more than 12,000 hours served last year, our D4DG is a highlight for our colleagues and local communities (6 years and counting, in fact)! Join us in helping through volunteer activities this week and share how you’re ”doing good” in the comments below ⬇️ | Regeneron
252 viewsOct 21, 2022
FacebookRegeneron
1:05
Regeneron is pursuing U.S. approval for its COVID-19 monoclonal antibody cocktail as a preventative treatment https://reut.rs/3daeHgE | Reuters
8.2K viewsApr 12, 2021
FacebookReuters
See more